معرفی
Marjolijn C.J. Jongmans serves as a Clinical Associate Professor in the medical field at Utrecht University, actively contributing to the Cancer Child Health strategic program. Her work bridges clinical practice and genetic research within pediatric oncology, focusing on improving outcomes for children with cancer through precision medicine approaches.
Her primary research domains encompass Pediatric Oncology, Cancer Genetics, and Child Health, with specialized expertise in Genetic Predisposition to Cancer, Hematological Malignancies in Children, Inborn Errors of Immunity, and Bone Marrow Failure Syndromes. She investigates how germline variants influence cancer development in pediatric populations, particularly examining immune dysfunction and bone marrow disorders that predispose children to malignancies.
Analysis of her 2025 publications reveals a strong emphasis on translating genetic discoveries into clinical practice. Her work integrates molecular profiling of pediatric cancers with psychosocial dimensions of genetic testing, highlighting both biological mechanisms and patient-centered care considerations in cancer predisposition syndromes.
Dr. Jongmans operates within Utrecht University's Child Health research ecosystem, collaborating extensively across European and North American institutions. Her strategic program affiliation demonstrates commitment to multidisciplinary approaches in childhood cancer surveillance and treatment development, leveraging institutional partnerships to advance pediatric precision oncology initiatives.
